April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Chemokines Receptors Expression in White Blood Cells Sub-Populations from Patients with Age-related Macular Degeneration
Author Affiliations & Notes
  • Itay Chowers
    Ophthalmology,
    Hadassah-Hebrew University Medical Center, Jerusalem, Israel
  • Michelle Grunin
    Ophthalmology,
    Hadassah-Hebrew University Medical Center, Jerusalem, Israel
  • Amnon Peled
    Gene Therapy Center,
    Hadassah-Hebrew University Medical Center, Jerusalem, Israel
  • Tal Burstyn-Cohen
    Ophthalmology,
    Hadassah-Hebrew University Medical Center, Jerusalem, Israel
  • Footnotes
    Commercial Relationships  Itay Chowers, None; Michelle Grunin, None; Amnon Peled, None; Tal Burstyn-Cohen, None
  • Footnotes
    Support  ISF, Israeli Ministry of Health
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 6635. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Itay Chowers, Michelle Grunin, Amnon Peled, Tal Burstyn-Cohen; Chemokines Receptors Expression in White Blood Cells Sub-Populations from Patients with Age-related Macular Degeneration. Invest. Ophthalmol. Vis. Sci. 2011;52(14):6635. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Experimental data from Age- related Macular Degeneration (AMD) patients and rodent models of the disease have implicated both chemokines receptors signaling and macrophages in the pathogenesis of AMD. However, their specific roles in the disease are not well understood. We aim to test the association among expression of chemokines receptors in sub-populations of white blood cells and AMD.

Methods: : Peripheral blood was drawn from treatment-naïve neovascular AMD (NV-AMD) patients (n=17; 9 females, 8 males) and age- matched control subjects (n=15; 8 females, 7 males). Immunophenotyping was performed on whole blood using antibodies recognizing various white blood cell types (T, B, and NK lymphocytes, CD14+CD16- and CD14+CD16+ monocytes). Expression of CCR1, CCR2, CCR5, CX3CR1, and CXCR4 chemokines receptors was assayed on each cell type by flow cytometry.

Results: : The number of cells belonging to each of the white blood cell sub-populations tested was similar in NV-AMD patients and controls. Average (±SEM) percentage of cells expressing CCR2 was increased in the sub-population of CD14+CD16+ monocytes from AMD patients (15.9±3.6) compared with controls (6.1±1.6; P=0.02; T-test). A trend towards increased CCR1 expression on CD14+CD16+ monocytes from AMD patients (7.4±2.5) vs. controls (2.5±0.8; P= 0.09; T-test) was also observed. CCR2 and CCR1 expression on T cells, B cells, NK cells, and CD14+CD16- subpopulation of monocytes were similar between patients and controls. Similarly, expression of CCR5, CX3CR1, and CXCR4 was similar in patients and controls on every cell type tested.

Conclusions: : Expression of the CCR2 chemokine receptor is up-regulated by the CD14+CD16+ subset of monocytes in NV-AMD patients. This data implicates CCR2 in the pathogenesis of NV-AMD. Additional investigation is required to elucidate whether increased CCR2 expression on monocytes underlie macrophage accumulation in retinas of AMD patients.

Keywords: age-related macular degeneration • gene/expression • inflammation 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×